1 completed. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
Follow Eye Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessment of the Anti-inflammatory Effects of Norflo Oro in Acute Relapses of HLA-B27 Associated Autoimmune Uveitis Norflo Oro, Placebo for Norflo Oro - Uveitis | Early Phase 1 | Completed | Eye Pharma | 49 | 2018-12-19 | 2022-03-28 |
Recurrence (1) · Uveitis (1)
United States (1)
Pia Allegri (1)